openPR Logo
Press release

Michael Haddad Appointed President of SouthStar Capital, LLC, Driving Strategic Growth in Commercial Finance

08-07-2025 11:34 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Michael Haddad Appointed President of SouthStar Capital, LLC,

Dallas, TX - August 7, 2025 - SouthStar Capital, LLC is proud to announce the appointment of Michael Haddad as President-a move that underscores the firm's commitment to strategic leadership and innovation in commercial finance.

Michael brings a distinguished background with more than 35 years of leadership experience in financial services and the banking industry. He has successfully built market share and enhanced profitability at top-tier companies in both independent and regulated environments, nationally and internationally, on numerous occasions. As President, he will lead SouthStar's expansion efforts, deepen client relationships, and drive operational excellence across the firm's portfolio.

"We are thrilled to welcome Michael as President," said Bernard Linney, Chief Executive Officer at SouthStar Capital. "His vision, precision, and leadership will be instrumental in shaping the next chapter of SouthStar's growth."

Michael Haddad, President of SouthStar Capital, stated:

"I'm honored to lead this effort at SouthStar Capital at such a pivotal time. My focus is on building a culture of strategic insight and operational discipline-empowering our clients with the financial tools they need to thrive nationwide. SouthStar's commitment to flexible, intelligent capital solutions aligns perfectly with my passion for uncovering value and driving results."

Michael's appointment reflects SouthStar's dedication to investing in top-tier leadership and delivering customized financial solutions to businesses nationwide.

For more information about SouthStar Capital, LLC, visit www.southstarcapital.com [http://www.southstarcapital.com/].

About SouthStar

SouthStar Capital, LLC is a nationwide commercial finance company with a 17-year track record of excellence, innovation, and customer satisfaction. We specialize in providing comprehensive, customized working capital solutions, including Accounts Receivable Financing, Asset-Based Lending, Purchase Order Financing, Equipment Leasing, Government Contracting, Invoice Factoring, and Payroll Funding.

Media Contact
Company Name: SouthStar Capital
Contact Person: Becca Ripley
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=michael-haddad-appointed-president-of-southstar-capital-llc-driving-strategic-growth-in-commercial-finance]
Phone: (843) 800-8339
Address:840 Lowcountry Blvd
City: Mount Pleasant
State: SC 29464
Country: United States
Website: http://www.southstarcapital.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Michael Haddad Appointed President of SouthStar Capital, LLC, Driving Strategic Growth in Commercial Finance here

News-ID: 4137695 • Views:

More Releases from ABNewswire

Alport Syndrome Clinical Landscape, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, and Pipeline Analysis | Enyo Pharma, Bayer
Alport Syndrome Clinical Landscape, Companies, Therapeutic Assessment, Therapies …
DelveInsight's, "Alport Syndrome - Pipeline Insight, 2025" report provides comprehensive insights about 4+ companies and 6+ pipeline drugs in Alport Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. According to DelveInsight, the Alport Syndrome pipeline features over 4
Pulmonary Fibrosis Clinical, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Bristol-Myers Squibb, PureTech Health, Sarepta Therapeutics, Boehringer Ingelheim, A
Pulmonary Fibrosis Clinical, Companies, Therapeutic Assessment, Therapies, Treat …
DelveInsight's, "Pulmonary Fibrosis - Pipeline Insight, 2025" report provides comprehensive insights about 110+ companies and 140+ pipeline drugs in Pulmonary Fibrosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. DelveInsight's analysis highlights that the Pulmonary Fibrosis pipeline features over
Irritable Bowel Syndrome Clinical, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline Analysis | Tryp Therapeutics, CinRx Pharma, Otsuka Pharmaceutical, RaQualia Pharma, Biomi
Irritable Bowel Syndrome Clinical, Companies, Therapeutic Assessment, Therapies, …
DelveInsight's, "Irritable Bowel Syndrome - Pipeline Insight, 2025" report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Irritable Bowel Syndrome pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. According to DelveInsight, the Irritable Bowel Syndrome (IBS)
Dengue Fever Clinical, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, and Pipeline Analysis | Johnson & Johnson, Novartis Pharmaceuticals, Merck Sharp & Dohme LLC, Panacea Biotec,
Dengue Fever Clinical, Companies, Therapeutic Assessment, Therapies, Treatment A …
DelveInsight's, "Dengue Fever - Pipeline Insight, 2025" report provides comprehensive insights about 8+ companies and 10+ pipeline drugs in Dengue Fever pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. According to DelveInsight, the Dengue Fever pipeline includes 8+ key

All 5 Releases


More Releases for SouthStar

SouthStar Powers Flooring Firm's Distribution Expansion with $500K
This deal was referred to SouthStar by an existing client and structured to support the company's renewed growth and expanding working capital needs. The business, which specializes in concrete flooring maintenance, surfacing, and polishing, primarily services large commercial and industrial spaces such as national retail distribution centers. With demand for warehouse flooring projects accelerating, the company needed a dependable source of liquidity to cover payroll, purchase materials, and keep operations moving. Although
SouthStar Capital Delivers Working Capital Boost to Functional Beverage Startup
SouthStar Capital is proud to announce the funding of an Accounts Receivable (A/R) Facility for a fast-growing omnichannel CPG company specializing in functional coffee and herbal tea blends. This early-stage company recently began receiving recurring purchase orders from a national retail chain and needed a reliable capital partner to support ongoing growth. After successfully fulfilling smaller orders, the company is now scaling production to meet increased demand. With invoices on Net
SouthStar Funds $2M A/R Facility for Industrial Equipment Manufacturer
SouthStar Capital, LLC is pleased to announce the funding of a $2 million Accounts Receivable facility for a Charlotte-based manufacturer of industrial battery handling systems. Serving several Fortune 500 companies nationwide, the business was in search of a reliable working capital solution after their long standing line of credit with a major bank was not renewed. With customer payment terms ranging from Net 30 to Net 60 and large system orders
SouthStar Capital Funds $2MM Facility for Expanding Lighting Solutions Company
Charleston, SC - SouthStar Capital, LLC is pleased to announce the funding of a $2 million combined Purchase Order (P/O) and Accounts Receivable (A/R) Facility for a lighting solutions company preparing for nationwide expansion. Specializing in commercial and residential lighting design, procurement, and distribution, the company is projected to generate $50 million in revenue from a new contract to supply lighting for up to 15,000 units. Previously working with multiple financing
SouthStar Capital Funds A/R Facility for Growing West Coast Construction Firm
Image: https://www.abnewswire.com/upload/2025/04/79d613e09986e7c62b7ce28aec64262b.jpg As the company rapidly expanded operations-particularly in water, storm, and sewer utility upgrades, as well as generator substation renovations-it needed faster access to working capital to support growth. With projected sales increasing from $1.66 million in 2024 to a $3.5 million target for 2025, cash flow gaps caused by 40-day payment terms and milestone billing cycles became a barrier to scaling. SouthStar Capital provided a strategic A/R Factoring solution, allowing
SouthStar Capital Provides $100,000 Accounts Receivable Facility to Stabilize St …
Image: https://www.abnewswire.com/uploads/911a474343589a1527163df1d67a8eca.png SouthStar Capital is excited to provide a $100,000 Accounts Receivable (A/R) facility to support the launch of a newly established staffing company. The company was spun off from a successful medical staffing business, which thrived during the COVID-19 pandemic by meeting the urgent demand for medical personnel. However, as the pandemic's impact lessened, the original business faced a slowdown, with one major debtor accounting for 80% of their accounts